These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


196 related items for PubMed ID: 29266359

  • 21. MiR-100-3p and miR-877-3p regulate overproduction of IL-8 and IL-1β in mesangial cells activated by secretory IgA from IgA nephropathy patients.
    Liang Y, Zhao G, Tang L, Zhang J, Li T, Liu Z.
    Exp Cell Res; 2016 Oct 01; 347(2):312-21. PubMed ID: 27542871
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Increased IgA and decreased IgG production by Epstein-Barr virus transformed B cells in culture in IgA nephropathy.
    Layward L, Allen AC, Harper SJ, Feehally J.
    Exp Nephrol; 1994 Oct 01; 2(1):24-9. PubMed ID: 8081994
    [Abstract] [Full Text] [Related]

  • 24. microRNA-630 Regulates Underglycosylated IgA1 Production in the Tonsils by Targeting TLR4 in IgA Nephropathy.
    Liu C, Ye MY, Yan WZ, Peng XF, He LY, Peng YM.
    Front Immunol; 2020 Oct 01; 11():563699. PubMed ID: 33324395
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    BMC Nephrol; 2017 Sep 29; 18(1):301. PubMed ID: 28969604
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Inhibition of miRNA-21 prevents fibrogenic activation in podocytes and tubular cells in IgA nephropathy.
    Bao H, Hu S, Zhang C, Shi S, Qin W, Zeng C, Zen K, Liu Z.
    Biochem Biophys Res Commun; 2014 Feb 21; 444(4):455-60. PubMed ID: 24468088
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy.
    Inoue T, Sugiyama H, Hiki Y, Takiue K, Morinaga H, Kitagawa M, Maeshima Y, Fukushima K, Nishizaki K, Akagi H, Narimatsu Y, Narimatsu H, Makino H.
    Clin Immunol; 2010 Sep 21; 136(3):447-55. PubMed ID: 20538527
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Role of let-7b in the regulation of N-acetylgalactosaminyltransferase 2 in IgA nephropathy.
    Serino G, Sallustio F, Curci C, Cox SN, Pesce F, De Palma G, Schena FP.
    Nephrol Dial Transplant; 2015 Jul 21; 30(7):1132-9. PubMed ID: 25744272
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. CagA, a major virulence factor of Helicobacter pylori, promotes the production and underglycosylation of IgA1 in DAKIKI cells.
    Yang M, Li FG, Xie XS, Wang SQ, Fan JM.
    Biochem Biophys Res Commun; 2014 Feb 07; 444(2):276-81. PubMed ID: 24462875
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.